rdf:type |
|
lifeskim:mentions |
umls-concept:C0001588,
umls-concept:C0021344,
umls-concept:C0024554,
umls-concept:C0042210,
umls-concept:C0043210,
umls-concept:C0238598,
umls-concept:C0332307,
umls-concept:C0355642,
umls-concept:C0445202,
umls-concept:C0677582,
umls-concept:C1325725,
umls-concept:C1707455
|
pubmed:issue |
5
|
pubmed:dateCreated |
2006-11-2
|
pubmed:abstractText |
Prophylactic vaccination of 16- to 23-year-old females with a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine has been shown to prevent type-specific human papillomavirus infection and associated clinical disease. We conducted a noninferiority immunogenicity study to bridge the efficacy findings in young women to preadolescent and adolescent girls and boys, who represent a primary target for human papillomavirus vaccination.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1098-4275
|
pubmed:author |
pubmed-author:BarrEliavE,
pubmed-author:BlockStan LSL,
pubmed-author:BryanJanine TJT,
pubmed-author:CastellsaguéXavierX,
pubmed-author:CavanaughPaul FPFJr,
pubmed-author:GiacolettiKatherine E DKE,
pubmed-author:Japanese and Korean Tolterodine Study Group,
pubmed-author:LukacSuzanneS,
pubmed-author:MarchantColin DCD,
pubmed-author:NolanTerryT,
pubmed-author:ReisingerKeith SKS,
pubmed-author:RuscheSteven ASA,
pubmed-author:SattlerCarlosC
|
pubmed:issnType |
Electronic
|
pubmed:volume |
118
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2135-45
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17079588-Adolescent,
pubmed-meshheading:17079588-Adult,
pubmed-meshheading:17079588-Age Factors,
pubmed-meshheading:17079588-Antibodies, Viral,
pubmed-meshheading:17079588-Child,
pubmed-meshheading:17079588-Female,
pubmed-meshheading:17079588-Humans,
pubmed-meshheading:17079588-Male,
pubmed-meshheading:17079588-Papillomaviridae,
pubmed-meshheading:17079588-Papillomavirus Vaccines,
pubmed-meshheading:17079588-Viral Vaccines
|
pubmed:year |
2006
|
pubmed:articleTitle |
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.
|
pubmed:affiliation |
Kentucky Pediatric Research, Inc, 201 S 5th St, Bardstown, KY 40004, USA. slblock@pol.net
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|